Bortezomib
- Product NDC
- 72266-244
- 11-digit product format
- 722660244
- Labeler code
- 72266
- Product ID
- 72266-244_e6718dc6-ebc8-570b-e053-2a95a90a86ba
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bortezomib
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- FOSUN PHARMA USA INC
- Application
- NDA215331
- Marketing category
- NDA
- Marketing start
- 2022-08-23
- Marketing end
- 0000-00-00
- Substance
- BORTEZOMIB
- Active strength
- 3 mg/1
- Pharmacologic classes
- Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72266-244-01 | 72266024401 | 1 INJECTION in 1 VIAL, SINGLE-DOSE (72266-244-01) | 1 injection | 2022-08-23 | 0000-00-00 | No | No | Current |